Cresanto Global Limited, formerly known as Raymed Labs Limited, will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, a limited review report for the same period, and a change in the company's corporate office and the location for maintaining its books of accounts. Trading window for designated persons will be closed from Wednesday, July 1, 2026, until 48 hours after the declaration of the unaudited financial results on August 13, 2026.